{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:57:57Z","timestamp":1782471477499,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.jinf.2008.05.005","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T09:55:39Z","timestamp":1213264539000},"page":"78-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins"],"prefix":"10.1016","volume":"57","author":[{"given":"S.","family":"Bonora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2008.05.005_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/14740338.4.5.821","article-title":"Drug\u2013drug interactions and tolerance in combining antituberculosis and antiretroviral therapy","volume":"4","author":"Di Perri","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"6 Suppl. 2","key":"10.1016\/j.jinf.2008.05.005_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1293.2005.00293.x","article-title":"BHIVA Guidelines Writing Committee BHIVA treatment guidelines for tuberculosis (TB)\/HIV infection 2005","author":"Pozniak","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.rmed.2006.01.002","article-title":"Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs","volume":"100","author":"Codecasa","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib5","author":"Bayer Schering Pharma"},{"key":"10.1016\/j.jinf.2008.05.005_bib6","doi-asserted-by":"crossref","first-page":"233S","DOI":"10.1592\/phco.21.16.233S.33992","article-title":"Pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"21","author":"Rodvold","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jinf.2008.05.005_bib7","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2165\/00003495-200666180-00003","article-title":"Tuberculosis and HIV co-infection: a practical therapeutic approach","volume":"66","author":"Breen","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jinf.2008.05.005_bib8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0924-8579(02)00239-X","article-title":"In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis","volume":"20","author":"Rodriguez","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2008.05.005_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/44.3.393","article-title":"Activity of moxifloxacin against mycobacteria","volume":"44","author":"Gillespie","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.200310-1380OC","article-title":"Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis","volume":"169","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200407-885OC","article-title":"Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis","volume":"170","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/joc.2003.15.1.66","article-title":"Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results","volume":"15","author":"Valerio","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.48.3.780-782.2004","article-title":"Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jac\/dki376","article-title":"Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis","volume":"56","author":"Gillespie","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.200603-360OC","article-title":"Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis","volume":"174","author":"Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2008.05.005_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1179\/joc.2006.18.6.617","article-title":"Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis","volume":"18","author":"Kubendiran","year":"2006","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.47.2.653-657.2003","article-title":"Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis","volume":"47","author":"Hu","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/dkh377","article-title":"Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?","volume":"54","author":"Di Perri","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2008.05.005_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(94)90044-2","article-title":"Clostridium difficile diarrhoea and rifabutin","volume":"343","author":"Pollock","year":"1994","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308001680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445308001680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:32:47Z","timestamp":1758987167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445308001680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0163445308001680"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2008.05.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2008.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}